WebSep 20, 2024 · CytoDyn Inc ( CYDY) stock is down -40.18% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives CYDY stock a score of 18 out of a possible 100. That rank is influenced by a fundamental score of 0. . CYDY's rank also includes a short-term technical score of 26. The long-term technical score for CYDY is 28. WebApr 13, 2024 · CytoDyn Inc (CYDY) stock is trading at $0.28 as of 9:33 AM on Wednesday, Apr 13, a gain of $0.01, or 5.62% from the previous closing price of $0.27. The stock has traded between $0.28 and $0.29 so far today. Volume today is light. So far 160,301 shares have traded compared to average volume of 2,523,368 shares.
CYDY CytoDyn Inc. Analyst Estimates & Rating – WSJ
WebPronunciation of Cydney with 3 audio pronunciations. 2 ratings. 0 rating. -1 rating. Record the pronunciation of this word in your own voice and play it to listen to how you have … WebSep 6, 2024 · Analyst Estimates Options Snapshot Stock Price Targets Yearly Numbers Estimates CYDY will report 2024 earnings on 08/02/2024 EPS Estimate 2024 2024 2024 -0.225 -0.2 -0.175 Quarterly Numbers... fish passage engineering design criteria
CYDY: CytoDyn - Options Chain - Zacks.com
WebJun 22, 2024 · Those who purchased CytoDyn Inc. (OTCQB:CYDY) shares should contact the Shareholders Foundation, Inc. CONTACT: Shareholders Foundation, Inc. Michael Daniels. +1 (858) 779-1554. mail ... WebView the basic CYDY option chain and compare options of CytoDyn Inc. on Yahoo Finance. WebNov 18, 2005 · CytoDyn has conducted two separate clinical trials investigating leronlimab for the treatment of COVID-19. A smaller trial, titled CD10, which included 86 patients, studied leronlimab’s effect on … candice huffine 2020